Jason Fontenot

Jason Fontenot

Company: Sangamo Therapeutics

Job title: Senior Vice President, Cell Therapy

Seminars:

BREAKOUT DISCUSSION GROUPS 12:00 pm

• What are the possible therapeutic approaches of gene therapies for diabetes and how do they compare with cell replacement approaches? • How can we optimize cell therapy efficacy through utilizing gene engineering mechanisms? • How can gene engineering be utilized to reduce alloimmune and autoimmune-mediated rejection of cells? • What is the importance and…Read more

day: Day Three

PANEL DISCUSSION: Advantages or Limitations of Cell and Gene Therapies 11:00 am

• Pros and cons of cells vs gene approaches • Gene transfer methods: non-viral vs. viral • Genetically engineering cells for enhanced efficacy • Cost vs. value of each methodology • What does the manufacturing strategy for these approaches look like?Read more

day: Day Three

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.